E
News ArticleSun Pharma Q1 Results: Sun Pharma reported a 27% YoY rise in Q1 net profit to Rs 2,895 crore, while revenue grew 10% to Rs 15,300 crore, driven by strong performance in India and its innovative medicines business despite weak US formulations sales. EBITDA rose 3% to Rs 4,418 crore. The company highl
Read the Full Story
This is a syndicated news brief. To read the complete, unabridged article and see all related media, please visit the original publisher.
Continue Reading on Economic Times